研究目的
To determine if the double-layer sign on structural OCT B-scans can predict the presence of subclinical macular neovascularization (MNV) in non-exudative age-related macular degeneration (AMD).
研究成果
The double-layer sign on structural OCT B-scans can predict the presence of subclinical type 1 MNV in non-exudative AMD with good predictive values, though SS-OCTA imaging is superior for detection.
研究不足
Use of SS-OCTA as the gold standard for the diagnosis of type 1 MNV may not detect all subclinical lesions that ICGA could. The study also did not use fluorescein angiography to detect subtle leakage in the absence of OCT structural changes.
1:Experimental Design and Method Selection:
Prospective, observational study using SS-OCTA imaging as the gold standard for detecting subclinical MNV. Structural OCT B-scans were graded for the presence of a double-layer sign.
2:Sample Selection and Data Sources:
Non-exudative AMD patients with and without subclinical MNV identified by SS-OCTA.
3:List of Experimental Equipment and Materials:
SS-OCTA (PLEX? Elite 9000; Carl Zeiss Meditec, Inc, Dublin, CA) with a 6x6 mm scan pattern centered on the fovea.
4:Experimental Procedures and Operational Workflow:
Graders evaluated structural OCT B-scans for the presence of a double-layer sign without access to flow information. Sensitivity, specificity, PPV, and NPV were calculated.
5:Data Analysis Methods:
Statistical analysis included Fisher exact test and Cohen’s Kappa statistic for agreement between ratings.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容